Teladoc Health Inc (TDOC) concluded trading on Thursday at a closing price of $7.24, with 6.0 million shares of worth about $43.46 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.88% during that period and on April 10, 2025 the price saw a loss of about -8.12%. Currently the company’s common shares owned by public are about 173.41M shares, out of which, 171.88M shares are available for trading.
Stock saw a price change of -3.85% in past 5 days and over the past one month there was a price change of -18.47%. Year-to-date (YTD), TDOC shares are showing a performance of -20.35% which decreased to -51.93% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.61 but also hit the highest price of $15.21 during that period. The average intraday trading volume for Teladoc Health Inc shares is 7.86 million. The stock is currently trading -10.36% below its 20-day simple moving average (SMA20), while that difference is down -26.26% for SMA50 and it goes to -21.91% lower than SMA200.
Teladoc Health Inc (NYSE: TDOC) currently have 173.41M outstanding shares and institutions hold larger chunk of about 73.69% of that.
The stock has a current market capitalization of $1.26B and its 3Y-monthly beta is at 1.80. It has posted earnings per share of -$5.88 in the same period. It has Quick Ratio of 1.69 while making debt-to-equity ratio of 1.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TDOC, volatility over the week remained 11.44% while standing at 6.34% over the month.
Stock’s fiscal year EPS is expected to rise by 83.91% while it is estimated to increase by 8.78% in next year. EPS is likely to grow at an annualized rate of 49.20% for next 5-years, compared to annual growth of -33.66% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on November 15, 2024 offering a Buy rating for the stock and assigned a target price of $14 to it. Coverage by Jefferies stated Teladoc Health Inc (TDOC) stock as a Hold in their note to investors on September 17, 2024, suggesting a price target of $10 for the stock. On February 29, 2024, Cantor Fitzgerald Initiated their recommendations, while on February 26, 2024, Leerink Partners Initiated their ratings for the stock with a price target of $17. Stock get a Neutral rating from DA Davidson on January 17, 2024.
